Macuira for Dry Aged Related Macula Degenration
- Home
- Macuira for Dry Aged Related Macula Degenration
Introducing MacuMira for Dry AMD
Embark on your journey toward clearer vision today with MacuMira, Canada’s premier clinically proven and regulatory approved treatment for Dry Age-Related Macular Degeneration (AMD).
Dry AMD, a chronic and progressive condition affecting over 2.6 million Canadians, is influenced by genetics, diabetes, and lifestyle factors such as diet and smoking. As vision deteriorates over time, everyday tasks like reading, driving, and independent living become increasingly challenging. In fact, AMD stands as the leading cause of adult blindness, affecting 9% of individuals over the age of 45. Treatment options range from lifestyle adjustments and supplements to eye injections in advanced stages, aiming to slow down disease progression.
MacuMira offers a groundbreaking solution, providing the first meaningful option to address vision loss associated with Dry AMD. Administered in eye-care clinics, this treatment is easy, safe, and effective, delivering immediate visual improvements.
Dry AMD, a chronic and progressive condition affecting over 2.6 million Canadians, is influenced by genetics, diabetes, and lifestyle factors such as diet and smoking. As vision deteriorates over time, everyday tasks like reading, driving, and independent living become increasingly challenging. In fact, AMD stands as the leading cause of adult blindness, affecting 9% of individuals over the age of 45. Treatment options range from lifestyle adjustments and supplements to eye injections in advanced stages, aiming to slow down disease progression.
MacuMira offers a groundbreaking solution, providing the first meaningful option to address vision loss associated with Dry AMD. Administered in eye-care clinics, this treatment is easy, safe, and effective, delivering immediate visual improvements.
HOW DOES MACUMIRA WORK?
- Utilizing a patented waveform, our headset delivers microcurrents across closed eyelids, stimulating and rejuvenating the Retinal Pigment Epithelium (RPE) cells at the back of the eye. This improved cellular function enhances energy production and facilitates the clearance of macular waste, leading to immediate and sustained visual improvements for up to 90 days.
OUR PROCESS
- Our process is easy and sustainable, ensuring client comfort and convenience. With MacuMira, you can trust that your vision therapy is administered by certified professionals, with immediate results and minimal disruption to your schedule.
KEY FEATURES OF MACUMIRA INCLUDE:
- Microcurrent delivery: Painless treatment without injections or adverse side effects.
- Patented waveform: Maximized efficacy while preserving delicate eye structures.
- Patented delivery system: Simple administration by certified eye-care practitioners.
- Immediate results: Optimal visual improvement after the initial treatment schedule.
- Visual improvements maintenance: Sustained with periodic treatments every 2-3 months.
- Mechanism of action: Stimulated RPE cells enhance cellular function and clear macular waste.
Choose MacuMira and embark on your journey to clearer, healthier vision today.
